Data from the Gore ASSURED Clinical Study demonstrated 100 percent closure success at six months
Jun 4, 2019
New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure
Sep 26, 2017
W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.
Aug 5, 2013
Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone
Apr 3, 2018